Clinical trial
Supplements, Placebo, or Rosuvastatin Study
NCT04846231 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Supplements, Placebo, or Rosuvastatin Study
- Lead sponsor
- The Cleveland Clinic
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 23, 2021
- Completion date
- July 19, 2022
- Enrollment
- 203 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.